BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23091851)

  • 21. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
    Glueck CJ; Fontaine RN; Wang P; Subbiah MT; Weber K; Illig E; Streicher P; Sieve-Smith L; Tracy TM; Lang JE; McCullough P
    Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PPAR-gamma2 Pro12Ala polymorphism in the population of obese and non-obese men of the city of Wroclaw.
    Kuliczkowska J; Filus A; Trzmiel A; Tworowska U; Demissie M; Jedrzejuk D; Milewicz A
    Endokrynol Pol; 2008; 59(4):312-5. PubMed ID: 18777501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flaxseed Oil Supplementation Improve Gene Expression Levels of PPAR-γ, LP(a), IL-1 and TNF-α in Type 2 Diabetic Patients with Coronary Heart Disease.
    Hashemzadeh AA; Nasoohi N; Raygan F; Aghadavod E; Akbari E; Taghizadeh M; Memarzadeh MR; Asemi Z
    Lipids; 2017 Nov; 52(11):907-915. PubMed ID: 28916975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes.
    Stefanski A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Pilarska K
    Arch Med Res; 2006 Aug; 37(6):736-43. PubMed ID: 16824933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of rosiglitazone and pioglitazone combined with metformin on the prothrombotic state of patients with type 2 diabetes mellitus and metabolic syndrome.
    Derosa G; Dangelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo S; Montagna L; Gravina A; Ferrari I; Galli S; Paniga S; Cicero AF
    J Int Med Res; 2006; 34(5):545-55. PubMed ID: 17133785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [12Ala polymorphism of receptor gene, which activates proliferation by peroxisome ά2, determines severity of bronchial asthma course associated with coronary heart disease].
    Georgian Med News; 2014 Apr; (229):40-7. PubMed ID: 24850604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of serum lipid/lipoprotein with Pro12Ala polymorphism in PPAR-γ2 among Chinese nonagenarians/centenarians.
    Chang-Quan H; Hui W; Qing-Xiu L; Gang C
    Arch Med Res; 2011 Oct; 42(7):613-9. PubMed ID: 22001700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
    Tjokroprawiro A
    Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes.
    Derosa G; Franzetti IG; Querci F; Carbone A; Ciccarelli L; Piccinni MN; Fogari E; Maffioli P
    Diabet Med; 2012 Dec; 29(12):1515-23. PubMed ID: 22540883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome.
    Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
    Arch Med Res; 2006 Jan; 37(1):86-94. PubMed ID: 16314192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [PPARdelta + 294T/C gene polymorphism related to plasma lipid, obesity and left ventricular hypertrophy in subjects with metabolic syndrome].
    Yan ZC; Shen CY; Zhong J; Wang L; Ni YX; Nie H; Zhu ZM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jun; 33(6):529-33. PubMed ID: 16053787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease.
    Ladeiras-Lopes R; Fontes-Carvalho R; Bettencourt N; Sampaio F; Gama V; Leite-Moreira A
    Expert Opin Ther Targets; 2015 Jul; 19(7):869-77. PubMed ID: 25762117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between PPAR-γ2 Pro12Ala genotype and insulin resistance is modified by circulating lipids in Mexican children.
    Stryjecki C; Peralta-Romero J; Alyass A; Karam-Araujo R; Suarez F; Gomez-Zamudio J; Burguete-Garcia A; Cruz M; Meyre D
    Sci Rep; 2016 Apr; 6():24472. PubMed ID: 27075119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Association of the hepatic lipase gene -250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease].
    Wei M; Lu YS; Li PP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):219-22. PubMed ID: 19350521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of the PPAR-gamma2 Pro12Ala and ACE I/D polymorphisms on insulin sensitivity and training effects in healthy offspring of type 2 diabetic subjects.
    Østergård T; Ek J; Hamid Y; Saltin B; Pedersen OB; Hansen T; Schmitz O
    Horm Metab Res; 2005 Feb; 37(2):99-105. PubMed ID: 15778927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pro12Ala polymorphism of the PPAR-γ2 gene, metabolic syndrome and response to metformin in clozapine-treated patients.
    Fernández E; Carrizo E; Connell L; Baptista T
    Schizophr Res; 2012 May; 137(1-3):262-3. PubMed ID: 22377103
    [No Abstract]   [Full Text] [Related]  

  • 38. Association between two common polymorphisms of PPARgamma gene and metabolic syndrome families in a Chinese population.
    Yang LL; Hua Q; Liu RK; Yang Z
    Arch Med Res; 2009 Feb; 40(2):89-96. PubMed ID: 19237017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular implications of antihyperglycemic therapies for type 2 diabetes.
    Ovalle F
    Clin Ther; 2011 Apr; 33(4):393-407. PubMed ID: 21635987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of complex therapy with metformin and ramipril combination for patients with metabolic syndrome].
    Kaĭdashev IP; Savchenko LH; Kaĭdasheva EI; Kutsenko NL; Kutsenko LO; Solokhina IL; Mamontova TV
    Lik Sprava; 2010; (7-8):77-84. PubMed ID: 21714292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.